Abstracts (HTML) List of Authors

Wagenhäuser, M

Impact of osteopontin on platelet adhesion and activation in intraluminal thrombus formation and abdominal aortic aneurysm progression

Wahler, S

Acquired Hemophilia A (AHA) Limits of the Awareness Push in Germany

Walenga, JM

Implementation of Direct Oral Anticoagulant (DOAC) Perioperative Interruption and Interval evaluation of the DOASENSE Dipstick performance

Wang, M

Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study

Wang, YJ

Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study

Watson, S

Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation

Weber, A

Heparinase treatment to remove the inhibitory heparin effect on the thrombin generation assay
Robust and selective chromogenic measurement of factor VIII activity with an antibody-based factor VIII chromogenic assay

Wei, XX

Development and validation of machine learning predictive models applying for cancer-associated deep vein thrombosis: A 1035-sample retrospective cohort study

Weiss, C

Interaction of direct oral anticoagulants and other anticoagulants on DOAC Dipstick test

Wenning, S

Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany

Werlen, L

Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation

Wermes, C

Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication

Werwitzke, S

von Willebrand factor (vWF) significantly modifies the sedimentation profile of FVIII-containing immune complexes (FVIII-IC) based on the type of anti-FVIII antibodies

Wesche, J

Platelets from patients with MYH9 related disorders are mechanically stiffer
Antibodies protect platelet damage by pneumolysin

Wieland, I

Acquired von Willebrand Syndrom (avWS) Typ 2 in children with severe pulmonary arterial hypertension (PAH)

Wieschhaus, K

Changes in Vascular Physiology in Patients with ESRD Compared to Patients with ESRD and Concomitant Cardiovascular Disorder

Willbold, D

Reelin supports Glycoprotein VI and integrin outside-in signaling of platelets

Willekens, G

A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation

Winkelmayer, W

Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm

Winterling, K

The Innovative Factor VIII Molecules HAT and HAT RI Overcome Impairments of Hemophilia A Therapy

Wohlrab, M

Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection

Wolff, M

Diagnosis of inherited platelet disorders: comparison between immunofluorescence analysis on the blood smear and genetic testing
In-vivo model to assess platelet age in humans: during increased platelet turnover large and small platelets are produced simultaneously

Wolny, M

Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery
Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation

Wuillemin, WA

A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland